Martin Fussenegger, Ph.D., and colleagues are using synthetic biology to develop next-generation cell therapies. In this video from Cell Reports, Dr. Fussenegger claims that “designer cells” are superior to small molecule–based treatments for diseases such as antibiotic-resistant infections (including MRSA) and implant-associated infections.